The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As they say Patience is a virtue
Best Wishes Karl
Hi Karl
My understanding is 80% of shares are with lth. Yes sellers have been exiting here for months. Again I saw this elsewhere but elsewhere the company delivered gains of 300% plus. Just waiting on news.
Yes I think at these prices it very attractive for any potential take over.
I believe also any recovery will be extremely fast but we must not forget there is also risk of the share falling further. But my thoughts it potentially at its rock bottom price .
Best wishes Karl
Hi Karl
Company currently valued at cash and not much else right now.
Looks very oversold to me.
Ongoing projects with cash rich partners could deliver huge milestone payments in the near term.
Reminds me of other plcs I have bought into when hardly anyone wanted to know them when they hit to the bottom. Any recovery could be large and fast, assuming no takeover approach which could be triggered.
Hello New Uncle.
First off all having lost loads of cash on a severe gamble, I have now calmed down severely looking for not only the positive aspects of a stock but also the bad .
The positive :Positive Aspects:
The company has licensing deals with leading developers like Sanofi and AstraZeneca, which could deliver up to $800 million in milestones2.
It has a robust cash position, with a runway until the first quarter of 2025 based on current cash burn rates.
The company has a reputation for unique expertise in Drug Discovery, attracting world-class partners in the pharmaceutical industry3.
The company’s CEO, Dr. Clive Dix, has stated that C4XD is in a strong position and is excited for its future.
My thoughts always consider the cash burn , it cant trade with no money
Hello Karl
Can you share your reasons for buying?
Tia
Just bought in today and wanted to wish you all good tidings for the future .
best wishes karl
I’m struggling to understand the value in this company right now and the potential it has
Brokers valuing this at circa 50p a share and it’s only 8p !!!
Nuts
Buyers taking cheap shares again today ahead of news on multiple projects soon
Still buying some here at the bottom fwiw.
Added some but MMs showing as sells fwiw
Https://uk.finance.yahoo.com/screener/insider/First%20Lucre%20Partnership%20Company
Interesting article and true. The next results will show profit because of the 15.9m and no doubt the next milestone payment from sanofi. So could be around £20m in revenue….add the cash and assets currently hold and an mcap of now less than 20m is kinda silly. Only retail shorts on this trying to get it down. Will keep adding as this will jump up quick shortly.
Agree with that. Looks like double bottom in. Squeeze time.
Well fwiw I am calling the bottom on these now.
Bring on the buyers and milestone payments which will be significant in Q1 2024.
I can wait and have the patience to outlast the short term girations here.
Good Luck to all genuine investors here for 2024.
Why would anyone short this now where current MCap is represented mostly by cash and there are partnered and other cash generating opportunities in the pipeline. Maybe someone auditioning for Brewsters Milluons 2
Amazing how that one short opened this morning has pushed it down but so difficult to buy.
FYI. All shorts now closed on C4xd this afternoon on IG. Had been a couple of short positions. They’ve closed out. Could be close to getting a blue finish to set it up nicely for the next few weeks/months. Remember the 50% plus open on the az news.
Yep something around that figure which is tiny. Avacta for example free float is around 90%. Even the likes of asos and boo is 50%
Quite a few of the holders are very close to tr1 threshold. Polar for example close to go 18%
Free Float is @20%....???
As it is under the radar. The wide spread doesn’t help as putting off buyers/traders. Lombard keep buying and one of those chunkier trades could have been a director buy today. Once it picks up it should move quite quickly as free float is small
Then again Shore Cap do make some very good calls IMO FWIW so why is no one buying at this massive discount?
Shore says Fair Value 55p.......wtf????
Could be well timed. I got the same. Had hovered at 8.15 but then it jumped. 8.66 to buy now. Some chunky trades today
Just added at 8.3p (shown on LSE as a sale) so reduced my average from 21p to 12p to keep within range should C4X become a takeover target. I’m positive on this company and see this as a bargain share. IMO and DYOR. Directors buying (if they can) would be nice and why wouldn’t they at this price?
Just as I posted. Broker note out and agree with it.
Yet investors may be tardy to the party, according to analysts: "We feel the recent weakness in the shares look unwarranted and would seem to discount some if not all of the potential we see across the pipeline."
https://www.proactiveinvestors.co.uk/companies/news/1036203/c4x-discovery-deals-a-strong-validation-of-prowess-in-drug-discovery-analyst-1036203.html?viewSource=TwitterUK